Abstract

BackgroundMalaria during pregnancy may result in unfavourable outcomes in both mothers and their foetuses. This study sought to document the current burden and factors associated with malaria and anaemia among pregnant women attending their first antenatal clinic visit in an area of Ghana with perennial malaria transmission.MethodsA total of 1655 pregnant women aged 18 years and above with a gestational age of 13–22 weeks, who attended an antenatal care (ANC) clinic for the first time, were consented and enrolled into the study. A structured questionnaire was used to collect socio-demographic and obstetric data and information on use of malaria preventive measures. Venous blood (2 mL) was collected before sulfadoxine-pyrimethamine administration. Malaria parasitaemia and haemoglobin concentration were determined using microscopy and an automated haematology analyser, respectively. Data analysis was carried out using Stata 14.ResultsMean age (SD) and gestational age (SD) of women at enrolment were 27.4 (6.2) years and 16.7 (4.3) weeks, respectively. Overall malaria parasite prevalence was 20.4% (95% CI 18.5–22.4%). Geometric mean parasite density was 442 parasites/µL (95% CI 380–515). Among women with parasitaemia, the proportion of very low (1–199 parasites/µL), low (200–999 parasites/µL), medium (1000–9999 parasites/µL) and high (≥ 10,000 parasites/µL) parasite density were 31.1, 47.0, 18.9, and 3.0%, respectively. Age ≥ 25 years (OR 0.57, 95% CI 0.41–0.79), multigravid (OR 0.50, 95% CI 0.33–0.74), educated to high school level or above (OR 0.53, 95% CI 0.33–0.83) and in household with higher socio-economic status (OR 0.34, 95% CI 0.21–0.54) were associated with a lower risk of malaria parasitaemia. The prevalence of anaemia (< 11.0 g/dL) was 56.0%, and the mean haemoglobin concentration in women with or without parasitaemia was 9.9 g/dL or 10.9 g/dL, respectively.ConclusionOne out of five pregnant women attending their first ANC clinic visit in an area of perennial malaria transmission in the middle belt of Ghana had Plasmodium falciparum infection. Majority of the infections were below 1000 parasites/µL and with associated anaemia. There is a need to strengthen existing malaria prevention strategies to prevent unfavourable maternal and fetal birth outcomes in this population.

Highlights

  • Malaria during pregnancy may result in unfavourable outcomes in both mothers and their foetuses

  • This study aimed at describing the prevalence and risk factors for malaria and anaemia among pregnant women living in an area of high malaria transmission in the middle belt of Ghana, prior to administration of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP)

  • Socio‐demographic, obstetric, clinical, and malaria vector prevention characteristics of study participants at enrolment A total of 1655 participants were eligible for inclusion in the study

Read more

Summary

Introduction

Malaria during pregnancy may result in unfavourable outcomes in both mothers and their foetuses. It was estimated that 228 million cases of malaria occurred worldwide in 2018 (decreased from 231 million cases in 2017), and that there were 405,000 deaths in 2018 compared to 416,000 in 2017. Most malaria cases (93%) and deaths (94%) occurred in the World Health Organization (WHO) Africa Region, with Plasmodium falciparum accounting for 99.7% of the cases [1]. Children under 5 years of age and pregnant women are the most at risk of malaria infection [2, 3]. In subSaharan Africa where moderate to high transmission of malaria occurs, an estimated 11 million out of 38 million (29%) pregnancies were exposed to malaria in 2018 [1]. Malaria in pregnancy is a useful marker for malaria surveillance at community level [7, 8] with common risk factors being a primagravida and being young [2, 9, 10]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call